Conditions: Post Herpetic Neuralgia
Keywords: Control Release Pregabalin in Post Herpetic Neuralgia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 806
Healthy volunteers: no

Brief summary:
The purpose of the study is to explore the safety and efficacy of a new once a day pregabalin formulation versus placebo for patients with post herpetic neuralgia (Shingles)

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Pregabalin intervention 2: placebo
Intervention descriptions: intervention 1: Tablets, 82.5 to 660mg, once per day. Duration: 19 weeks intervention 2: Placebo, 82.5 to 660mg, once per day. Duration: 13 weeks

Protocol document: